Anesthesiology APPLIED Exam › Endocrine, renal, hepatic and metabolic

Postoperative jaundice: is anesthesia the cause?

Endocrine, renal, hepatic and metabolic·~5 min read· Physician-reviewed✓ Sourced · 3

Stem

A 71-year-old woman, 68 kg, had an open right hemicolectomy for an obstructing cecal cancer under sevoflurane. The record shows 1.5 L of blood loss, three units of red cells, and 20 minutes of MAP near 55 mmHg during mobilization. She is receiving piperacillin-tazobactam. At your visit on postoperative day two her sclerae are yellow and total bilirubin is 4.1 mg/dL. Her daughter, a pharmacist, asks whether the anesthetic gas has damaged her mother's liver.

Question

What do you tell the daughter, and how will you work up the jaundice?

Ideal answer

HeadlineWe will find the cause rather than guess: your mother has three common causes already, and volatile hepatitis is vanishingly rare with modern agents.¹

Chart and anesthetic record first, showing hypotension, transfusion and drugs; then the bilirubin fraction and the enzymes.
Pattern points to mechanism: unconjugated means production or uptake (hemolysis, hematoma resorption, Gilbert syndrome); hepatocellular, high transaminases (ischemia, viral hepatitis, a drug); cholestatic, high alkaline phosphatase and conjugated bilirubin (sepsis, drugs, biliary obstruction).
Her three: transfusion, hypotension, an antibiotic, because jaundice after surgery is usually multifactorial: transfusion, resorbing hematoma, hypotension, sepsis, drug-induced cholestasis. Volatile hepatitis is a diagnosis of exclusion.
Fractionated bilirubin, transaminases, alkaline phosphatase, LDH, haptoglobin, smear; ultrasound for suspected obstruction, hepatology if transaminases are above 1,000.
I document what I find and update her, her daughter (with her permission) and the surgeon, because the record guides her future anesthetics.

Breaking down the answer

Organize before you defend — pre-hepatic, hepatic and post-hepatic, not a reflex to blame or excuse the volatile; this grades organization and the communication behind a possible drug reaction.
Pre-hepatic: bilirubin overload — stored red cells carry senescent cells that hemolyze, classically about 250 mg of bilirubin per unit; a large hematoma does the same. Hemolytic transfusion reaction, G6PD deficiency and sickle crisis belong here: a direct Coombs test too.
Hepatic: ischemic hepatitis — transaminases in the thousands, often 20–50 times normal, within 24–48 hours of hypotension or hypoxemia, with only a modest bilirubin rise and a quick fall once perfusion is restored.² The record shows the low pressure; recovery is the rule.
Hepatic: drugs — antibiotics (amoxicillin-clavulanate is the classic), azoles, acetaminophen, TPN and anti-epileptics are far more common culprits than anesthetics.
Volatile hepatitis — an immune reaction to trifluoroacetylated liver proteins; severe halothane hepatitis follows about 1 in 15,000 first and 1 in 1,000 repeat exposures; isoflurane and desflurane cause it far less, being metabolized much less.¹
Who gets it — sevoflurane forms no trifluoroacetyl metabolites, though rare cases are reported. Risks: prior exposure (especially with fever or jaundice after it), obesity, older age; most reports are middle-aged women. Onset 2–14 days, often with fever and, in up to 30%, eosinophilia.¹
Post-hepatic and sepsis — a retained stone or bile duct injury shows dilated ducts on ultrasound, and the surgeon needs to know today; sepsis cytokines impair bile transport, raising bilirubin with a modest enzyme change that resolves with source control.

Follow-up question

Her bilirubin settles, but on day 9 she returns for washout of an anastomotic leak under desflurane. The next day the AST is 1,800, with fever, eosinophilia and a rash, and the surgeon says "anesthesia hepatitis" in front of her family. What do you do?

Follow-up answer

HeadlineThe picture fits immune-mediated volatile hepatitis but is not yet proven; I neither agree nor argue in the hall.

I exclude ischemia, sepsis from the leak, viral hepatitis and other drugs, including her antibiotic, involve hepatology, and check for anti-TFA antibodies if available. I tell the family honestly what we know and what we are testing. I document the reaction, report it, and recommend that future anesthetics avoid all halogenated volatile agents, sevoflurane included, using a total intravenous technique.¹ I follow the INR and mental status daily; a rising INR or encephalopathy means acute liver failure, and I recommend early transfer to a transplant center.

Pitfalls that cost points

Blaming or excusing the anesthetic before building a differential.
Missing ischemic hepatitis by not reviewing the intraoperative record.
Delaying imaging when obstruction is possible.

Rapid-fire

Q: Why is halothane different from sevoflurane? A: Roughly 20% or more of halothane is metabolized by CYP2E1 to the trifluoroacetyl hapten;¹ sevoflurane is about 3–5% metabolized to hexafluoroisopropanol, which does not form it.

Q: How does type 1 halothane injury differ from type 2? A: Type 1 is a mild, common, dose-related transaminase rise; type 2 is the rare immune-mediated fulminant hepatitis.

Q: How do you classify the enzyme pattern? A: The R ratio, ALT over ULN divided by ALP over ULN: 5 or more is hepatocellular, below 2 cholestatic, between is mixed.³

Q: Does Gilbert syndrome worry you? A: No; unmasked by fasting and stress, it is benign.

Q: When does ischemic hepatitis peak? A: Transaminases peak in 1–3 days and fall by at least half within 72 hours of restoring perfusion, normalizing in 5–10 days.²

Numbers to know

Item	Value
Clinical jaundice	Bilirubin > 2.5–3 mg/dL
Bilirubin per unit of stored blood	~250 mg (classic teaching)
Severe halothane hepatitis	~1 in 15,000 first exposures; ~1 in 1,000 repeat¹
Halothane metabolism	~20% or more, via CYP2E1¹
Ischemic hepatitis	AST/ALT > 1,000 within 24–48 h; halves within 72 h²
Hepatocellular pattern	R ratio ≥ 5; cholestatic < 2³

Sources

1.Halothane (LiverTox: Clinical and Research Information on Drug-Induced Liver Injury) · NIDDK / NCBI Bookshelf, 2018 · ncbi.nlm.nih.govSevere injury ~1 in 15,000 after first exposure, ~1 in 1,000 after repeat; avoid all halogenated agents after halothane hepatitis.
2.Hypertransaminasemia in non-cirrhotic critically-ill patients · World Journal of Hepatology, 2025 · wjgnet.comHypoxic liver injury: ALT/AST 20–50× ULN, fall ≥50% within 72 h of stabilization.
3.Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury (ACG guideline summary) · American College of Gastroenterology (MDCalc) · mdcalc.com

Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.